Search Results

1

Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphoma

by Dawson, K., Felizzi, F., Guzauskas, G.F, Launonen, A., Masaquel, A., Spencer, S.J, Veenstra, D.L
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
2

Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020–2025

by Arnason, J.A, Ge, W., Kanas, G., Keeven, K., Nersesyan, K., Quek, R.G.W
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
3

Mantle cell lymphoma, malt lymphoma, small lymphocytic lymphoma, and follicular lymphoma of the oral cavity: An update

by Aguirre-Urizar, J.M, Barra, M.B, Carvalho, M.V.R, dos Santos, J.N, Fonseca, F.P, Hunter, K.D, Martins, M.D, Rodrigues-Fernandes, C.I, van Heerden, W.F.P, Vargas, P.A, Wagner, V.P
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article